Glimco-MP2 contains Glimepiride 2mg, Metformin 500mg, and Pioglitazone 15mg SR. This triple therapy improves insulin sensitivity, increases glucose uptake, and enhances pancreatic insulin release.
It is ideal for patients needing aggressive multi-targeted sugar control. Blister pack ensures protection from humidity.
Reviews
There are no reviews yet.